First Header Logo Second Header Logo

Girish Mishra

Concepts (218)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endosonography
19
2018
56
3.550
Why?
Adenocarcinoma
10
2010
315
1.230
Why?
Pancreatic Neoplasms
7
2006
142
1.060
Why?
Biliary Tract
2
2012
7
0.780
Why?
Biliary Tract Diseases
2
2012
12
0.770
Why?
Cholestasis
2
2012
18
0.750
Why?
Pancreatic Cyst
3
2018
4
0.690
Why?
Biopsy, Fine-Needle
6
2009
53
0.640
Why?
Incidental Findings
1
2017
27
0.590
Why?
Digestive System Diseases
1
2016
6
0.560
Why?
Lymphatic Diseases
2
2012
10
0.500
Why?
Lymph Nodes
2
2012
106
0.470
Why?
Endoscopy, Gastrointestinal
4
2018
25
0.430
Why?
Kidney Transplantation
1
2017
518
0.420
Why?
Pancreatitis, Acute Necrotizing
2
2018
6
0.410
Why?
Humans
39
2018
32297
0.380
Why?
Colonoscopy
2
2018
45
0.360
Why?
Pancreatic Pseudocyst
1
2010
5
0.360
Why?
Gastrostomy
1
2010
17
0.360
Why?
Retrospective Studies
11
2018
3514
0.350
Why?
Sensitivity and Specificity
6
2012
600
0.330
Why?
Pseudomyxoma Peritonei
1
2008
12
0.330
Why?
Liver Diseases
1
2009
70
0.320
Why?
Pancreatitis, Chronic
3
2016
9
0.300
Why?
Cholangiopancreatography, Endoscopic Retrograde
4
2016
33
0.300
Why?
Appendiceal Neoplasms
1
2008
98
0.290
Why?
Female
25
2018
20126
0.290
Why?
Esophageal Neoplasms
4
2010
35
0.290
Why?
Male
23
2018
19488
0.290
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2010
462
0.280
Why?
Middle Aged
20
2018
11949
0.280
Why?
Liver
2
2009
486
0.280
Why?
Adult
16
2018
9467
0.280
Why?
Telomerase
1
2006
22
0.270
Why?
Follow-Up Studies
5
2017
2296
0.270
Why?
DNA, Neoplasm
1
2006
56
0.270
Why?
Aged
16
2018
10398
0.270
Why?
Peritoneal Neoplasms
1
2008
263
0.260
Why?
DNA
1
2006
229
0.250
Why?
Cholecystectomy, Laparoscopic
2
2016
18
0.230
Why?
Fluorodeoxyglucose F18
3
2010
56
0.220
Why?
Recombinant Fusion Proteins
1
2003
103
0.220
Why?
Hepatitis C
1
2003
41
0.220
Why?
Diagnosis, Differential
3
2012
525
0.210
Why?
Veterans
1
2003
66
0.210
Why?
Aged, 80 and over
9
2016
4050
0.200
Why?
Necrosis
1
2018
56
0.160
Why?
Pancreatectomy
1
2018
32
0.160
Why?
Journal Impact Factor
1
2018
11
0.160
Why?
Antineoplastic Agents
1
2003
611
0.160
Why?
Deoxycytidine
3
2010
68
0.160
Why?
Pancreatitis
3
2011
22
0.150
Why?
Predictive Value of Tests
4
2016
877
0.150
Why?
Curriculum
2
2012
210
0.150
Why?
Radiopharmaceuticals
3
2010
94
0.150
Why?
Pancreas
4
2010
104
0.150
Why?
Academic Medical Centers
1
2018
160
0.150
Why?
Periodicals as Topic
1
2018
101
0.140
Why?
Choledocholithiasis
1
2016
3
0.140
Why?
Preoperative Care
1
2017
116
0.140
Why?
Self Concept
1
2016
42
0.140
Why?
Intraoperative Care
1
2016
49
0.140
Why?
Needles
1
2016
31
0.130
Why?
Activities of Daily Living
1
2016
258
0.130
Why?
Colonic Polyps
2
2018
15
0.120
Why?
Esophagectomy
2
2010
15
0.110
Why?
Prognosis
1
2017
1523
0.110
Why?
Abdomen
1
2012
45
0.110
Why?
Child, Preschool
1
2016
1281
0.100
Why?
Ultrasonography, Interventional
1
2012
53
0.100
Why?
Radiotherapy, Adjuvant
3
2010
77
0.100
Why?
Child
2
2016
2472
0.100
Why?
Positron-Emission Tomography
2
2010
190
0.100
Why?
Cholelithiasis
1
2011
12
0.100
Why?
Combined Modality Therapy
6
2011
567
0.090
Why?
Comorbidity
2
2011
572
0.090
Why?
Adolescent
2
2016
3571
0.090
Why?
Prospective Studies
4
2016
2274
0.090
Why?
Quality of Life
1
2016
915
0.090
Why?
Young Adult
1
2017
2626
0.090
Why?
Catheterization
1
2010
59
0.090
Why?
Immunohistochemistry
2
2009
545
0.090
Why?
Gallbladder Neoplasms
1
2009
36
0.080
Why?
Multivariate Analysis
3
2010
696
0.080
Why?
Bile Duct Neoplasms
1
2009
36
0.080
Why?
Survival Rate
3
2006
894
0.080
Why?
Drug Administration Schedule
2
2006
279
0.080
Why?
Radiography
1
2009
377
0.080
Why?
Evidence-Based Medicine
1
2009
217
0.070
Why?
Forecasting
1
2008
145
0.070
Why?
Liver Neoplasms
1
2009
159
0.070
Why?
Clinical Competence
2
2007
331
0.070
Why?
Genes, ras
1
2006
25
0.070
Why?
Kidney Neoplasms
1
2009
201
0.070
Why?
False Positive Reactions
1
2006
31
0.070
Why?
Celiac Plexus
1
2006
3
0.070
Why?
Autoimmune Diseases
1
2006
49
0.070
Why?
Disease Progression
2
2006
618
0.070
Why?
Bile Duct Diseases
1
2006
10
0.070
Why?
Nerve Block
1
2006
51
0.070
Why?
Neoadjuvant Therapy
1
2006
67
0.070
Why?
Polymerase Chain Reaction
1
2006
190
0.070
Why?
Risk Assessment
2
2009
1447
0.070
Why?
Thrombocytopenia
1
2005
32
0.070
Why?
Vomiting
1
2005
25
0.070
Why?
Cross-Sectional Studies
2
2016
1522
0.060
Why?
Camptothecin
1
2005
53
0.060
Why?
Liver Cirrhosis, Alcoholic
1
2005
2
0.060
Why?
Education, Medical
1
2006
70
0.060
Why?
Colchicine
1
2005
8
0.060
Why?
Nausea
1
2005
54
0.060
Why?
Gastrointestinal Diseases
1
2005
43
0.060
Why?
Diarrhea
1
2005
60
0.060
Why?
Abdominal Pain
1
2005
45
0.060
Why?
Fatigue
1
2005
85
0.060
Why?
Rectal Neoplasms
1
2005
18
0.060
Why?
Disease-Free Survival
1
2005
320
0.060
Why?
Severity of Illness Index
1
2008
926
0.060
Why?
Cholangiography
2
2016
11
0.060
Why?
Mutation
1
2006
503
0.060
Why?
Genes, erbB-1
1
2003
15
0.060
Why?
Pain
1
2006
305
0.060
Why?
Diphtheria Toxin
1
2003
23
0.060
Why?
Radiotherapy Dosage
3
2010
101
0.060
Why?
Injections
1
2003
65
0.060
Why?
Georgia
1
2003
14
0.060
Why?
Angioedema
1
2003
3
0.060
Why?
Viscera
1
2003
17
0.060
Why?
Enalapril
1
2003
8
0.060
Why?
Internship and Residency
1
2007
306
0.060
Why?
Florida
1
2003
37
0.060
Why?
Prisoners
1
2003
11
0.060
Why?
Treatment Outcome
4
2018
3358
0.060
Why?
Hospitals, Veterans
1
2003
38
0.050
Why?
Neoplasm Staging
3
2010
459
0.050
Why?
Stomach Diseases
1
2002
7
0.050
Why?
Chemotherapy, Adjuvant
3
2010
191
0.050
Why?
Choristoma
1
2002
18
0.050
Why?
Cell Survival
1
2003
301
0.050
Why?
Biopsy, Needle
1
2002
98
0.050
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2003
141
0.050
Why?
Gastrectomy
1
2002
67
0.050
Why?
Liver Transplantation
1
2003
179
0.050
Why?
Substance-Related Disorders
1
2003
124
0.050
Why?
Socioeconomic Factors
1
2003
422
0.050
Why?
Cell Line, Tumor
1
2003
736
0.050
Why?
Double-Blind Method
2
2016
550
0.040
Why?
Reproducibility of Results
2
2016
779
0.040
Why?
Disinfection
1
2018
5
0.040
Why?
Barrett Esophagus
1
2018
3
0.040
Why?
Equipment Contamination
1
2018
11
0.040
Why?
Microscopy, Confocal
1
2018
67
0.040
Why?
False Negative Reactions
2
2011
22
0.040
Why?
Inflammatory Bowel Diseases
1
2018
29
0.040
Why?
Adenoma
1
2018
39
0.040
Why?
Surgery, Computer-Assisted
1
2018
56
0.040
Why?
Cohort Studies
3
2009
1832
0.040
Why?
Tomography, X-Ray Computed
3
2011
920
0.040
Why?
Hospital Mortality
1
2018
197
0.040
Why?
Disease Management
1
2018
131
0.040
Why?
Length of Stay
1
2018
315
0.040
Why?
Stents
1
2018
180
0.040
Why?
Factor Analysis, Statistical
1
2016
75
0.030
Why?
Videotape Recording
1
2016
13
0.030
Why?
Phantoms, Imaging
1
2016
61
0.030
Why?
United States
2
2018
3983
0.030
Why?
Colorectal Neoplasms
1
2018
222
0.030
Why?
Psychometrics
1
2016
137
0.030
Why?
Risk Factors
1
2003
3876
0.030
Why?
Carcinoma, Squamous Cell
2
2006
154
0.030
Why?
Survival Analysis
2
2005
491
0.030
Why?
Chronic Disease
2
2005
406
0.030
Why?
Education, Medical, Continuing
1
2012
57
0.030
Why?
Animals
1
2003
7694
0.020
Why?
Cholagogues and Choleretics
1
2011
3
0.020
Why?
Technetium Tc 99m Lidofenin
1
2011
3
0.020
Why?
Ursodeoxycholic Acid
1
2011
4
0.020
Why?
Cholangiopancreatography, Magnetic Resonance
1
2011
8
0.020
Why?
Ceftriaxone
1
2011
12
0.020
Why?
Antibiotic Prophylaxis
1
2011
38
0.020
Why?
Radiography, Interventional
1
2011
37
0.020
Why?
Platinum Compounds
1
2010
3
0.020
Why?
Age of Onset
1
2011
100
0.020
Why?
Remission Induction
1
2010
84
0.020
Why?
Paclitaxel
1
2010
67
0.020
Why?
Obesity
1
2018
1164
0.020
Why?
Medical Records
1
2010
77
0.020
Why?
Neurosurgical Procedures
1
2011
100
0.020
Why?
Fluorouracil
1
2010
82
0.020
Why?
Contrast Media
1
2010
140
0.020
Why?
Observer Variation
1
2010
109
0.020
Why?
Video Recording
1
2010
57
0.020
Why?
Adenoma, Oxyphilic
1
2009
4
0.020
Why?
Hospitals, Teaching
1
2009
32
0.020
Why?
Probability
1
2009
160
0.020
Why?
Confidence Intervals
1
2009
150
0.020
Why?
Carcinoma, Renal Cell
1
2009
114
0.020
Why?
Conscious Sedation
1
2007
24
0.020
Why?
Monitoring, Intraoperative
1
2007
42
0.020
Why?
Anesthesia
1
2007
64
0.020
Why?
Injections, Intravenous
1
2006
79
0.020
Why?
Survival
1
2006
13
0.020
Why?
Tomography, Emission-Computed
1
2005
23
0.020
Why?
Recurrence
1
2006
266
0.020
Why?
Postoperative Complications
1
2011
788
0.020
Why?
Morbidity
1
2005
98
0.020
Why?
Treatment Failure
1
2005
171
0.020
Why?
Dose-Response Relationship, Drug
1
2006
675
0.020
Why?
Mediastinum
1
2004
14
0.010
Why?
Chi-Square Distribution
1
2005
302
0.010
Why?
Diagnosis, Computer-Assisted
1
2004
61
0.010
Why?
Neoplasm Recurrence, Local
1
2006
370
0.010
Why?
Ultrasonography
1
2006
398
0.010
Why?
Ethnic Groups
1
2006
480
0.010
Why?
Practice Guidelines as Topic
1
2006
410
0.010
Why?
Laparoscopy
1
2002
171
0.010
Why?
Algorithms
1
2002
497
0.010
Why?
Hypertension
1
2003
972
0.010
Why?
Mishra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (218)
Explore
_
Co-Authors (11)
Explore
_
Similar People (50)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_